Press Release: Living cells as an "active drug" Advances in image-guided cell therapy promise breakthrough in the treatment of cancer and diabetes ENCITE Video launch
For three patients, each affected by one of today’s major health care problems – diabetes, cancer and cardiovascular disease – cell therapy represents a promising treatment. Transplanted living cells act as an “active drug” by producing hormones, destroying tumour cells or regenerating damaged tissues. However, there is a major hurdle to be overcome before these novel cell therapies can be made available to patients… The mechanisms underlying how cell therapy works are poorly understood. To watch the video, please visit the ENCITE website (www.encite.org) and/or download the file here. ENCITE has made a real impact on the treatment of healthcare problems that affect our every day lives. To better understand how cell therapy works, prominent researchers have been working together to develop imaging tools for novel cellular therapies. The ENCITE scientists have joined forces to translate important research developments into clinical practice…Helping to make cellular therapy a reality, not just a future dream. Details on the latest news:http://www.encite.org/cms/website.php Contact: European Institute for Biomedical Imaging Research (EIBIR), Project Coordination Neutorgasse 9, 1010 Vienna (AT) Phone: +43-1-5334064-20 / office@eibir.org / www.eibir.org http://www.encite.org/cms/website.php(opens in new window) Scientific Coordinator: Prof. Gabriel P. Krestin, ERASMUS MC, ehaas@eibir.org ###
Countries
Austria, Belgium, Bulgaria, Cyprus, Czechia, Germany, Denmark, Estonia, Greece, Spain, Finland, France, Hungary, Ireland, Italy, Lithuania, Luxembourg, Latvia, Malta, Netherlands, Poland, Portugal, Romania, Sweden, Slovenia, Slovakia, United Kingdom